These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 36445009)
1. Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Gandini A; Gonçalves AE; Strocchi S; Albertini C; Janočková J; Tramarin A; Grifoni D; Poeta E; Soukup O; Muñoz-Torrero D; Monti B; Sabaté R; Bartolini M; Legname G; Bolognesi ML ACS Chem Neurosci; 2022 Dec; 13(23):3314-3329. PubMed ID: 36445009 [TBL] [Abstract][Full Text] [Related]
2. Alleviatory effects of Danshen, Salvianolic acid A and Salvianolic acid B on PC12 neuronal cells and Drosophila melanogaster model of Alzheimer's disease. Tan FHP; Ting ACJ; Leow BG; Najimudin N; Watanabe N; Azzam G J Ethnopharmacol; 2021 Oct; 279():114389. PubMed ID: 34217797 [TBL] [Abstract][Full Text] [Related]
3. Distinctive alteration in the expression of autophagy genes in Drosophila models of amyloidopathy and tauopathy. Haghi M; Masoudi R; Najibi SM Ups J Med Sci; 2020 Nov; 125(4):265-273. PubMed ID: 32657227 [TBL] [Abstract][Full Text] [Related]
4. Applications of Immunomagnetic Reduction Technology as a Biosensor in Therapeutic Evaluation of Chinese Herbal Medicine in Tauopathy Alleviation of an AD Su MT; Lu CW; Wu WJ; Jheng YS; Yang SY; Chuang WC; Lee MC; Wu CH Biosensors (Basel); 2022 Oct; 12(10):. PubMed ID: 36291020 [TBL] [Abstract][Full Text] [Related]
5. Dual Inhibitors of Amyloid-β and Tau Aggregation with Amyloid-β Disaggregating Properties: Extended Pasieka A; Panek D; Szałaj N; Espargaró A; Więckowska A; Malawska B; Sabaté R; Bajda M ACS Chem Neurosci; 2021 Jun; 12(11):2057-2068. PubMed ID: 34019757 [TBL] [Abstract][Full Text] [Related]
6. Dual targeting of acetylcholinesterase and tau aggregation: Design, synthesis and evaluation of multifunctional deoxyvasicinone analogues for Alzheimer's disease. Manzoor S; Gabr MT; Rasool B; Pal K; Hoda N Bioorg Chem; 2021 Nov; 116():105354. PubMed ID: 34562674 [TBL] [Abstract][Full Text] [Related]
7. The distinctive role of tau and amyloid beta in mitochondrial dysfunction through alteration in Mfn2 and Drp1 mRNA Levels: A comparative study in Drosophila melanogaster. Abtahi SL; Masoudi R; Haddadi M Gene; 2020 Sep; 754():144854. PubMed ID: 32525045 [TBL] [Abstract][Full Text] [Related]
8. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model. Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W; J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262 [TBL] [Abstract][Full Text] [Related]
9. Active full-length DNA Aβ Rosenberg RN; Fu M; Lambracht-Washington D Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039 [TBL] [Abstract][Full Text] [Related]
10. The calcineurin inhibitor Sarah (Nebula) exacerbates Aβ42 phenotypes in a Drosophila model of Alzheimer's disease. Lee S; Bang SM; Hong YK; Lee JH; Jeong H; Park SH; Liu QF; Lee IS; Cho KS Dis Model Mech; 2016 Mar; 9(3):295-306. PubMed ID: 26659252 [TBL] [Abstract][Full Text] [Related]
11. Cinnamaldehyde Improves Lifespan and Healthspan in Pham HM; Xu A; Schriner SE; Sevrioukov EA; Jafari M Biomed Res Int; 2018; 2018():3570830. PubMed ID: 30228985 [TBL] [Abstract][Full Text] [Related]
12. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain]. Watanabe H Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372 [TBL] [Abstract][Full Text] [Related]
13. DNT1 Downregulation and Increased Ethanol Sensitivity in Transgenic Drosophila Models of Alzheimer's Disease. Nikookar H; Haddadi M; Haghi M; Masoudi R Arch Gerontol Geriatr; 2021; 94():104355. PubMed ID: 33550108 [TBL] [Abstract][Full Text] [Related]
14. Dual modulators of aggregation and dissociation of amyloid beta and tau: In vitro, in vivo, and in silico studies of Uncaria rhynchophylla and its bioactive components. Kim S; Nam Y; Shin SJ; Prajapati R; Shin SM; Kim MJ; Soo Kim H; Leem SH; Kim TJ; Park YH; Kim JJ; Choi JS; Moon M Biomed Pharmacother; 2022 Dec; 156():113865. PubMed ID: 36242849 [TBL] [Abstract][Full Text] [Related]
15. An Isoquinolinium Dual Inhibitor of Cholinesterases and Amyloid β Aggregation Mitigates Neuropathological Changes in a Triple-Transgenic Mouse Model of Alzheimer's Disease. Ju Y; Chakravarty H; Tam KY ACS Chem Neurosci; 2020 Oct; 11(20):3346-3357. PubMed ID: 33001625 [TBL] [Abstract][Full Text] [Related]
16. Differential dysregulation of CREB and synaptic genes in transgenic Drosophila melanogaster expressing shaggy (GSK3), Tau Ataellahi F; Masoudi R; Haddadi M Mol Biol Rep; 2023 Feb; 50(2):1101-1108. PubMed ID: 36399243 [TBL] [Abstract][Full Text] [Related]
17. 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease. Wichur T; Więckowska A; Więckowski K; Godyń J; Jończyk J; Valdivieso ÁDR; Panek D; Pasieka A; Sabaté R; Knez D; Gobec S; Malawska B Eur J Med Chem; 2020 Feb; 187():111916. PubMed ID: 31812794 [TBL] [Abstract][Full Text] [Related]
18. Salvianolic acids modulate lifespan and gut microbiota composition in amyloid-β-expressing Drosophila melanogaster. Go W; Ishak IH; Zarkasi KZ; Azzam G World J Microbiol Biotechnol; 2024 Oct; 40(11):358. PubMed ID: 39428437 [TBL] [Abstract][Full Text] [Related]
20. Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease. Iijima K; Gatt A; Iijima-Ando K Hum Mol Genet; 2010 Aug; 19(15):2947-57. PubMed ID: 20466736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]